MarketWise, Inc. (MKTW) Stock Price & Analysis

MarketWise, Inc. (MKTW) closed at USD 18.83 on Friday, October 23, 2026, up 1.95% on the day. The US market is currently closed; this is not a live price.

The prior close was USD 18.83; the Oct 23, 2026 session ranged USD 18.31–18.87 on volume of 10,862 shares. Market capitalization is —, with a 52-week range of USD 13.49–22.83 (NGM). Source: Nexqual, retrieved October 24, 2026 at 01:37 UTC.

Also available as compact Markdown for AI agents: nexqual.com/MKTW.md

Key facts (MKTW)

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (MKTW)

USDFY2021FY2022FY2023FY2024FY2025TTM
Revenue$549M$512M$448M$409M$328M$318M
Gross profit$310M$450M$391M$358M$284M—
Operating income-$968M$87.3M$51.8M$89.0M$62.6M$25.7M
Net income-$1.01B$18.0M$1.8M$7.1M$5.6M$2.2M
EPS (diluted)—$14.60$1.07$3.58$2.31—
Free cash flow$63.5M$48.3M$62.4M-$22.3M$45.6M$45.9M
Gross margin56.4%87.8%87.3%87.6%86.5%—
Operating margin-176.2%17.0%11.6%21.8%19.1%8.1%
Net margin-184.5%3.5%0.4%1.7%1.7%0.7%
Revenue growth+50.8%-6.7%-12.5%-8.8%-19.7%—
Cash + short-term investments$139M$159M$155M$97.9M$70.1M—
Total debt——$0K———

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (MKTW)

P/E at fiscal year-ends: Dec 2025 6.5x, Dec 2024 3.2x, Dec 2023 51.0x.

Insider sales (SEC Form 4, open-market, last ~7 months) (MKTW)

0 of 3 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

Trade dateInsiderRoleSharesValue% of holdings sold10b5-1 planInsider type
2026-07-01Galsim MarcoChief Information Officer3,294$63K7.7%NoToo little history (no open-market trades in 2023–2025)
2026-07-01Forney Scott DanielGeneral Counsel711$14K3.2%NoToo little history (no open-market trades in 2023–2025)
2026-07-01Mickels ErikChief Finacial Officer3,973$76K5%NoOpportunistic (traded every year 2023–2025, no repeating month)

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Insider purchases (SEC Form 4, open-market, last ~7 months) (MKTW)

5 purchases, $2.1M. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.

Trade dateInsiderRoleSharesValueAvg priceInsider type
2026-05-22Stansberry Frank PorterDirector10,000$179K17.88Too little history (no open-market trades in 2024 or 2025)
2026-05-20Stansberry Frank PorterDirector20,100$346K17.21Too little history (no open-market trades in 2024 or 2025)
2026-05-15…2026-05-18Stansberry Frank PorterDirector3,634$60K16.5Too little history (no open-market trades in 2024 or 2025)
2026-05-12…2026-05-14Stansberry Frank PorterDirector30,000$547K18.25Too little history (no open-market trades in 2024 or 2025)
2026-05-08…2026-05-11Stansberry Frank PorterDirector51,375$975K18.97Too little history (no open-market trades in 2024 or 2025)

Total return (dividends reinvested) (MKTW)

1Y (from 2025-10-24)5Y (from 2021-10-25)
Total return+41.3%-81.2%
S&P 500 (SPY)+13.4%+76.9%
Per year+41.5%-28.5%
Volatility (annualized)53.0%67.9%
Max drawdown-20.5% (Jan 2026→Mar 2026)-93.0% (Nov 2021→Nov 2024)

MKTW revenue by product line (quarter ended Jun 30, 2026)

LineRevenueShare of totalYoY
Subscriptions$75.3M99.4%-5.0%
Advertising$13,0000.0%+18.2%
Total revenue$75.8M100%—

MKTW revenue by region (fiscal year ended Dec 31, 2025)

LineRevenueShare of totalYoY
United States$328.1M100.0%-19.7%
Total revenue$328.1M100%—

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

MKTW company outlook (results filed Aug 6, 2026)

Quoted word-for-word from the SEC 8-K results press release.

MKTW analyst estimates and revisions

PeriodEPS estimate90 days agoChangeRevenue estimateAnalysts
Current quarter (ends Sep 2026)$0.32$0.64-50.1%$78.5M1
Next quarter (ends Dec 2026)$0.76$0.73+4.4%$83.5M1
Current fiscal year (ends Dec 2026)$0.63$1.87-66.4%$314.8M1
Next fiscal year (ends Dec 2027)$3.02$2.54+19.0%$344.6M2

Key Statistics (as of October 24, 2026 at 01:37 UTC)

PriceUSD 18.83
Change▲ 1.95% (up)
Previous CloseUSD 18.83
OpenUSD 18.83
Day RangeUSD 18.31 – 18.87
52-Week RangeUSD 13.49 – 22.83
Volume10,862 shares
Market Cap—
ExchangeNGM

Technical Analysis (MKTW)

Nexqual's technical model rates MKTW "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of October 24, 2026 at 01:37 UTC.

Overall SignalSELL
RSI (14)49.84 (neutral)
vs SMA50Above (USD 18.72)
MACD-0.1 (negative)

Earnings (MKTW)

Revenue Estimate$78.47M

Recent Earnings History

QuarterActual vs Estimate
2026-06-30USD -0.24 vs est 0.71 ▼ miss
2026-03-31USD -0.23 vs est 0.67 ▼ miss
2025-12-31USD 0.76 vs est -0.22 ▲ beat
2025-09-30USD 0.58 vs est -1.32 ▲ beat

Source: Nexqual, October 24, 2026 at 01:37 UTC.

Financials & Fundamentals (MKTW)

Total Revenue$317.50M
Revenue Growth (latest quarter, YoY)-5.20%
Gross Margin+86.02%
Operating Margin-5.61%
Profit Margin+0.70%
Current Ratio0.35
Total Cash$32.91M
Total Debt$5.54M

Source: Nexqual, October 24, 2026 at 01:37 UTC.

Ownership (MKTW)

Insider Ownership+26.93%
Institutional Ownership+31.31%
Shares Outstanding2.79M
Float1.76M
Short % of Float+2.58%

Source: Nexqual, October 24, 2026 at 01:37 UTC.

From MarketWise, Inc.'s Latest SEC 10-K Filing (filed 2026-03-06)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Legal & Regulatory Risks (Item 1A, quoted)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
TGLOtheglobe.com, inc.USD 0.15▲ 0.33%
SEEKTHEDIRECTORY.COMUSD 0▲ 0%
INKTMiNK Therapeutics, Inc.USD 10.71▲ 6.46%
MLTXMoonLake ImmunotherapeuticsUSD 11.85▼ 3.97%
CNETZW Data Action Technologies IncUSD 1.07▼ 2.73%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 01:37 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt